Aviv Regev, a core institute member of the Broad Institute of MIT and Harvard, will become head of Genentech research and early development on Aug. 1.
Millions across the globe are struggling with their mental health, and the COVID-19 pandemic is compounding a crisis that has been ignored throughout history. The U.S. alone spent $89 ...
Scientists at UK biotech PrecisionLife say they have used the UK Biobank to identify human genes that can
Johnson & Johnson taps Khan for chief data role; Icon poaches AstraZeneca vet Buck as CMO; Intellia signs on Lebwohl as CMO.
Venture capital firm Frazier Healthcare has grabbed Scott Byrd, Ian Mills, and Gordon McMurray as its new Entrepreneur-in-Residence consultants.
Just a few months after Alexion snapped up complement inhibitor biotech Achillion, Gemini Therapeutics has nabbed one of its key R&D execs as its new chief medical officer.